The application of catheter-based renal sympathetic denervation in clinical practice: Recent progress in clinical research

Journal of Interventional Radiology (China)

Volumn 22, Issue 1, 2013, Pages 1-7

  Zhou, Geng ^a   Lu, Chuan ^a   Cheng, Yong De ^a  

^a TAISHAN MEDICAL UNIVERSITY   (China)

Author keywords

Ablation; Clinical application; Complication; Interventional radiology; Renal sympathetic nerve

Indexed keywords

CATHETER ABLATION; CATHETER BASED SYMPATHETIC DENERVATION; CLINICAL PRACTICE; DENERVATION; HUMAN; NOTE; PATHOPHYSIOLOGY; SURGICAL TECHNIQUE; SYMPATHETIC NERVE; VASCULAR SURGERY;

EID: 84875484151     PISSN: 1008794X     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1008-794X.2013.01.001     Document Type: Note

References (37)

1. Hoobler SW, Manning JT, Paine WG, et al. The effects of splanchnicectomy on the blood pressure in hypertension; a controlled study[J]. Circulation, 1951, 4: 173-183.
2. Schlaich MP, Sobotka PA, Krum H, et al. Renal sympathetic - nerve ablation for uncontrolled hypertension [J]. N Engl J Med, 2009, 361: 932-934.
3. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study [J]. Lancet, 2009, 373: 1275-1281.
4. Mahfoud F, Schlaich M, Kindermann I, et al. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study [J]. Circulation, 2011, 123: 1940-1946.
5. Schlaich MP, Hering D, Sobotka P, et al. Effects of renal denervation on sympathetic activation, blood pressure, and glucose metabolism in patients with resistant hypertension [J]. Front Physiol, 2012, 3: 10.
6. DiBona GF. Sympathetic nervous system and the kidney in hypertension[J]. Curr Opin Nephrol Hypertens, 2002, 11: 197-200. (Pubitemid 34194740)
7. Ziegler AK, Franke J, Bertog SC. Renal denervation in a patient with prior renal artery stenting [J]. Catheter Cardiovasc Interv, 2012, 28: 1-24.
8. Symplicity HTN- 1 Investigateors. Catheter-Based renal sympathetic denervation for resistant hypertension durability of blood pressure reduction out to 24 months [J]. Hypertension, 2011, 57: 911-917.
9. Symplicity HTN-2 Investigators, Esler MD, Krum H, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial [J]. Lancet, 2010, 376: 1903-1909.
10. Zuern CS, Rizas KD, Eick C, et al. Effects of renal sympathetic denervation on 24-hour blood pressure variability [J]. Front Physiol, 2012, 3: 134.
11. Himmel F, Bode F, Mortensen K, et al. Successful single-sided renal denervation approach in a patient with stenosis of an accessory renal artery[J]. J Clin Hypertens (Greenwich), 2012, 14: 187-188.
12. Brandt MC, Mahfoud F, Reda S, et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension[J]. J Am Coll Cardiol, 2012, 59: 901-909.
13. Ukena C, Bauer A, Mahfoud F, et al. Renal sympathetic denervation for treatment of electrical storm: first-in-man experience[J]. Clin Res Cardiol, 2012, 101: 63-67.
14. Ukena C, Mahfoud F, Kindermann I, et al. Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension [J]. J Am Coll Cardiol, 2011, 58: 1176-1182.
15. Triposkiadis F, Karayannis G, Giamouzis G, et al. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications [J]. J Am Coll Cardiol, 2009, 54: 1747-1762.
16. Sobotka PA, Mahfoud F, Schlaich MP, et al. Sympatho-renal axis in chronic disease[J]. Clin Res Cardiol, 2011, 100: 1049-1057.
17. Masuo K, Mikami H, Ogihara T, et al. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population [J]. Am J Hypertens, 1997, 10: 77-83. (Pubitemid 27038975)
18. Mancia G, Bousquet P, Elghozi JL, et al. The sympathetic nervous system and the metabolic syndrome [J]. J Hypertens, 2007, 25: 909-920. (Pubitemid 46573105)
19. Huggett RJ, Scott EM, Gilbey SG, et al. Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension[J]. Circulation, 2003, 108: 3097-3101. (Pubitemid 38031798)
20. Straznicky NE, Grima MT, Lambert EA, et al. Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals [J]. J Hypertens, 2011, 29: 553-564.
21. Schlaich MP, Sobotka PA, Krum H, et al. Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept[J]. Hypertension, 2009, 54: 1195-1201.
22. Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, et al. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension[J]. Chest, 2007, 131: 453-459.
23. Witkowski A, Prejbisz A, Florczak E, et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea[J]. Hypertension, 2011, 58: 559-565.
24. Lara HE, Ferruz JL, Luza S, et al. Activation of ovarian sympathetic nerves in polycystic ovary syndrome [J]. Endocrinology, 1993, 133: 2690-2695. (Pubitemid 24000721)
25. Sverrisdóttir YB, Mogren T, Kataoka J, et al. Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?[J]. Am J Physiol Endocrinol Metab, 2008, 294: E576-E581. (Pubitemid 351355228)
26. Schlaich MP, Straznicky N, Grima M, et al. Renal denervation: a potential new treatment modality for polycystic ovary syndrome? [J]. J Hypertens, 2011, 29: 991-996.
27. Oparil S, Narkiewicz K, Kjeldsen S, et al. Renal nerve ablation: emerging role in therapeutics[J]. Blood Press, 2011, 20: 253-255.
28. Martin EA, Victor RG. Premise, promise, and potential limitations of invasive devices to treat hypertension [J]. Curr Cardiol Rep, 2011, 13: 86-92.
29. Sapoval M, Azizi M, Bobrie G, et al. Endovascular renal artery denervation: why, when, and how? [J]. Cardiovasc Intervent Radiol, 2012, 35: 463-471.
30. Prochnau D, Figulla HR, Romeike BF, et al. Percutaneous catheter-based cryoablation of the renal artery is effective for sympathetic denervation in a sheep model [J]. Int J Cardiol, 2011, 152: 268-270.
31. Egbelakin A, Ferguson MJ, Macgill EA, et al. Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia [J]. Pediatr Blood Cancer, 2011, 56: 361-367.
32. Stefanadis C. Renal denervation in resistant hypertension: radiofrequency ablation and chemical denervation[J]. Hellenic J Cardiol, 2011, 52: 481-482.
33. Mahfoud F, Himmel F, Ukena C, et al. Treatment strategies for resistant arterial hypertension[J]. Dtsch Arztebl Int, 2011, 108: 725-731.
34. Doumas M, Faselis C, Papademetriou V. Renal sympathetic denervation and systemic hypertension [J]. Curr Opin Nephrol Hypertens, 2010, 105: 570-576.
35. Simonetti G, Spinelli A, Gandini R, et al. Endovascular radiofrequency renal denervation in treating refractory arterial hypertension: a preliminary experience [J]. Radiol Med, 2012, 117: 426-444.